Guy Brusselle

42.5k total citations · 10 hit papers
445 papers, 22.8k citations indexed

About

Guy Brusselle is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Guy Brusselle has authored 445 papers receiving a total of 22.8k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Pulmonary and Respiratory Medicine, 268 papers in Physiology and 59 papers in Immunology. Recurrent topics in Guy Brusselle's work include Asthma and respiratory diseases (240 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (160 papers) and Respiratory and Cough-Related Research (94 papers). Guy Brusselle is often cited by papers focused on Asthma and respiratory diseases (240 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (160 papers) and Respiratory and Cough-Related Research (94 papers). Guy Brusselle collaborates with scholars based in Belgium, Netherlands and United States. Guy Brusselle's co-authors include Guy Joos, Ken R. Bracke, Bruno H. Stricker, Tania Maes, Lies Lahousse, Ingel Demedts, Ian Pavord, Marc Humbert, Ruben Pauwels and Katia Verhamme and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Medicine.

In The Last Decade

Guy Brusselle

423 papers receiving 22.3k citations

Hit Papers

Mepolizumab Treatment in ... 2011 2026 2016 2021 2014 2015 2016 2011 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    2014 1.6k citations Ian Pavord, Guy Brusselle et al. profile →
  2. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
    2015 840 citations Michael E. Wechsler, Guy Brusselle et al. The Lancet Respiratory Medicine profile →
  3. Treatable traits: toward precision medicine of chronic airway diseases
    2016 653 citations Guy Brusselle, Peter G. Gibson et al. European Respiratory Journal profile →
  4. New insights into the immunology of chronic obstructive pulmonary disease
    2011 588 citations Guy Brusselle, Guy Joos et al. profile →
  5. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
    2012 527 citations Guy Brusselle, Paul Van Cauwenberge et al. profile →
  6. Objectives, design and main findings until 2020 from the Rotterdam Study
    2020 316 citations M. Arfan Ikram, Guy Brusselle et al. profile →
  7. The Rotterdam Study: 2018 update on objectives, design and main results
    2017 312 citations M. Arfan Ikram, Guy Brusselle et al. profile →
  8. The Rotterdam Study: 2016 objectives and design update
    2015 295 citations Guy Brusselle, Oscar H. Franco et al. profile →
  9. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
    2023 178 citations Louis‐Philippe Boulet, Guy Brusselle et al. profile →
  10. The Rotterdam Study. Design update and major findings between 2020 and 2024
    2024 54 citations M. Arfan Ikram, Guy Brusselle et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Guy Brusselle 12.5k 12.1k 4.3k 2.6k 2.5k 445 22.8k
Alberto Papi 14.1k 1.1× 12.5k 1.0× 4.2k 1.0× 1.9k 0.7× 1.3k 0.5× 501 22.7k
Pascal Chanez 14.6k 1.2× 18.7k 1.5× 5.1k 1.2× 2.0k 0.8× 4.5k 1.8× 447 25.6k
Charles G. Irvin 9.6k 0.8× 12.0k 1.0× 3.6k 0.8× 1.7k 0.7× 2.8k 1.1× 221 18.4k
Eugene R. Bleecker 14.7k 1.2× 19.7k 1.6× 5.0k 1.2× 1.9k 0.7× 3.3k 1.4× 332 25.3k
Christopher E. Brightling 17.3k 1.4× 21.1k 1.7× 7.0k 1.6× 2.6k 1.0× 3.6k 1.5× 496 29.1k
Romain Pauwels 18.3k 1.5× 17.6k 1.5× 3.2k 0.8× 1.3k 0.5× 2.9k 1.2× 146 26.3k
Robert F. Lemanske 10.8k 0.9× 14.8k 1.2× 3.7k 0.9× 1.7k 0.7× 3.1k 1.3× 209 20.6k
Leonardo M. Fabbri 27.9k 2.2× 19.0k 1.6× 3.4k 0.8× 3.0k 1.2× 1.5k 0.6× 487 39.5k
E. Haydn Walters 11.3k 0.9× 9.3k 0.8× 1.3k 0.3× 1.3k 0.5× 2.1k 0.8× 525 19.2k
Paul M. O’Byrne 22.7k 1.8× 30.4k 2.5× 6.6k 1.5× 2.4k 0.9× 7.6k 3.1× 556 38.1k

Countries citing papers authored by Guy Brusselle

Since Specialization
Citations

This map shows the geographic impact of Guy Brusselle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Brusselle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Brusselle more than expected).

Fields of papers citing papers by Guy Brusselle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Brusselle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Brusselle. The network helps show where Guy Brusselle may publish in the future.

Co-authorship network of co-authors of Guy Brusselle

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Brusselle. A scholar is included among the top collaborators of Guy Brusselle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Brusselle. Guy Brusselle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Grymonprez, Maxim, et al.. (2025). Cardiovascular safety of biologic therapies in patients with severe asthma: a nationwide cohort study in Belgium. The Lancet Regional Health - Europe. 57. 101420–101420. 2 indexed citations
3.
Bourdin, Arnaud, Guy Brusselle, Simon Couillard, et al.. (2024). Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics. The Journal of Allergy and Clinical Immunology In Practice. 12(4). 809–823. 24 indexed citations
4.
Boulet, Louis‐Philippe, Carl Abbott, Guy Brusselle, et al.. (2024). Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1244–1253.e8. 2 indexed citations
5.
Pizzichini, Emílio, et al.. (2024). Run-in periods and treatment outcomes in asthma trials: A narrative review. Contemporary Clinical Trials Communications. 42. 101382–101382. 1 indexed citations
6.
Ross, James C., Rosa Faner, Michael H. Cho, et al.. (2023). Clinical relevance of lung function trajectory clusters in middle-aged and older adults. ERJ Open Research. 10(1). 793–2023.
7.
Froidure, Antoine, Benjamin Bondue, Caroline Dahlqvist, et al.. (2023). Clinical course of suspected familial and sporadic idiopathic pulmonary fibrosis: Data from the PROOF‐Next registry. Respirology. 29(4). 304–311. 3 indexed citations
8.
Reddel, Helen K., Guy Brusselle, Rosa Lamarca, et al.. (2023). Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy. The Journal of Allergy and Clinical Immunology In Practice. 11(7). 2104–2114.e3. 2 indexed citations
9.
Benz, Elizabeth, Lies Lahousse, Sara Wijnant, et al.. (2023). Oral corticosteroid use and sarcopenia-related traits in older people with chronic airway disease: a population-based study. ERJ Open Research. 9(5). 492–2023. 5 indexed citations
10.
Bos, Daniël, et al.. (2023). Epidemiology of unexplained chronic cough in adults: a population-based study. ERJ Open Research. 9(3). 739–2022. 12 indexed citations
11.
Rabe, Klaus F., et al.. (2019). Dupilumab effect on asthma control and health-related quality of life in patients with oral corticosteroid-dependent severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps. Ghent University Academic Bibliography (Ghent University). 3 indexed citations
12.
Fricker, Michael, Hannelore Van Eeckhoutte, Anne Verhamme, et al.. (2019). Necroptosis is activated in and drives pathogenesis of COPD. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
13.
Seys, Leen, W. Widagdo, Anne Verhamme, et al.. (2018). DPP4, the MERS coronavirus receptor, is upregulated in lungs of smokers and COPD patients. Lirias (KU Leuven).
14.
Santiago, Guido Lopes dos Santos, Guy Brusselle, Kenny Dauwe, et al.. (2017). Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma. BMC Microbiology. 17(1). 109–109. 26 indexed citations
15.
Jaspers, Loes, Josje D. Schoufour, Nicole S. Erler, et al.. (2017). Development of a Healthy Aging Score in the Population-Based Rotterdam Study: Evaluating Age and Sex Differences. Journal of the American Medical Directors Association. 18(3). 276.e1–276.e7. 27 indexed citations
16.
Baarsma, Hoeke A., Wioletta Skrońska-Wąsek, Kathrin Mutze, et al.. (2016). Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD. The Journal of Experimental Medicine. 214(1). 143–163. 118 indexed citations
17.
Papi, Alberto, Pascal Chanez, Maciej Kupczyk, et al.. (2014). Frequent exacerbators - a distinct phenotype of severe asthma. Homo Politicus (Academy of Humanities and Economics in Lodz). 116 indexed citations
18.
Mehuys, Els, Guy Brusselle, Thierry Van Hees, et al.. (2014). Self-medication in persistent rhinitis: overuse of decongestants in half of the patients. Ghent University Academic Bibliography (Ghent University). 5 indexed citations
19.
Verhamme, Katia, et al.. (2013). Chronic kidney disease as effect modifier in the association between the use of tiotropium respimat and mortality. European Respiratory Journal. 42(Suppl 57). 4632–4632. 1 indexed citations
20.
Cauwenberge, Paul Van, et al.. (2007). Cross-sectional exploration of upper airway status in an asthmatic population. Ghent University Academic Bibliography (Ghent University). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Papi Breakdown of academic impact, for papers by Pascal Chanez Breakdown of academic impact, for papers by Charles G. Irvin Breakdown of academic impact, for papers by Eugene R. Bleecker Breakdown of academic impact, for papers by Christopher E. Brightling Breakdown of academic impact, for papers by Romain Pauwels Breakdown of academic impact, for papers by Robert F. Lemanske Breakdown of academic impact, for papers by Leonardo M. Fabbri Breakdown of academic impact, for papers by E. Haydn Walters Breakdown of academic impact, for papers by Paul M. O’Byrne
Rankless by CCL
2026